Sarcopenic Obesity and Risk of Disability in Community-Dwelling Japanese Older Adults: A 5-Year Longitudinal Study

肌萎缩 肌萎缩性肥胖 医学 危险系数 肥胖 人口 纵向研究 老年学 比例危险模型 物理疗法 内科学 置信区间 环境卫生 病理
作者
Masanori Morikawa,Sang Yoon Lee,Keitaro Makino,Kenji Harada,Osamu Katayama,Kouki Tomida,Ryo Yamaguchi,Chiharu Nishijima,Kazuya Fujii,Yuka Misu,Mitsuhiro Katashima,Hiroyuki Shimada
出处
期刊:Journal of the American Medical Directors Association [Elsevier BV]
卷期号:24 (8): 1179-1184.e1 被引量:41
标识
DOI:10.1016/j.jamda.2023.03.008
摘要

Objectives Previous studies have indicated that sarcopenic obesity is a risk factor for disability onset. However, these studies had disparities in terms of criteria for sarcopenia, study design, or study population. No longitudinal study has investigated the effect of sarcopenic obesity on disability onset in an Asian population using the Asian Working Group for Sarcopenia 2019 criteria for sarcopenia definition. Herein, we aimed to investigate the longitudinal effect of sarcopenic obesity on disability onset in Japanese older adults and extend the generalizability of results to other populations. Design Longitudinal cohort study. Setting and Participants A total of 4197 Japanese older adults (mean age 74.6 ± 5.0 years, 54.2% women) formed our study population. Measurements Sarcopenia was identified using the Asian Working Group for Sarcopenia 2019 algorithm. Obesity was determined when body fat percentage was ≥25%, or when visceral fat content was ≥100 cm2 for either sex. Disability onset was defined as a new case of long-term care insurance system certification for 5 years from baseline. Missing values were managed with multi-imputation. Cox proportional hazard regression analysis was used with disability onset as dependent variable and group (nonsarcopenia/nonobesity as a reference, nonsarcopenia/obesity, sarcopenia/non-obesity, possible sarcopenia/obesity, possible sarcopenia/non-obesity, sarcopenic obesity) as explanatory variable, and was adjusted for potential confounding factors. Results When the nonsarcopenia/nonobesity group was used as the reference category, other groups such as possible-sarcopenia/nonobesity [hazard ratio (HR) 1.38, 95% confidential interval (95% CI) 1.29‒1.47, P < .028], possible-sarcopenia/obesity (HR 1.54, 95% CI 1.46‒1.62 P < .001), sarcopenia/nonobesity (HR 2.09, 95% CI 1.96‒2.23, P < .001), and sarcopenic obesity (HR 2.48, 95% CI 2.24‒2.75, P < .001) showed significantly increased HRs. Conclusions and Implications The risk of disability onset because of sarcopenic obesity was exceedingly higher compared with sarcopenia alone among community-dwelling older adults in Japan The health providers should consider assessing the co-existence of sarcopenia and obesity to screen for the risk of disability onset in the community-dwelling population.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
蛋又白完成签到,获得积分10
刚刚
852的应助被HE采纳,获得10
刚刚
刚刚
刚刚
1秒前
yhtsyy发布了新的文献求助10
1秒前
秋风的应助被安详的飞烟采纳,获得20
1秒前
1秒前
逃跑的炸鸡完成签到 ,获得积分10
1秒前
淋巴细胞发布了新的文献求助10
1秒前
每天睡不醒的应助被sunhaoxue采纳,获得10
2秒前
2秒前
Firsterchao发布了新的文献求助30
2秒前
赘婿的应助被winwin采纳,获得10
3秒前
3秒前
xcli完成签到,获得积分10
3秒前
3秒前
123发布了新的文献求助10
3秒前
4秒前
4秒前
4秒前
Kiki完成签到,获得积分10
4秒前
ding的应助被zhoushishan采纳,获得10
4秒前
5秒前
5秒前
5秒前
俏皮麦片发布了新的文献求助20
6秒前
orixero的应助被cyq采纳,获得10
6秒前
sxy发布了新的文献求助10
6秒前
热心又蓝完成签到,获得积分10
6秒前
6秒前
7秒前
w1kend发布了新的文献求助10
7秒前
芽芽发布了新的文献求助10
7秒前
呆头鹅完成签到,获得积分10
7秒前
8秒前
9秒前
Liu发布了新的文献求助30
9秒前
Kiki发布了新的文献求助10
9秒前
bkagyin的应助被没用的鱿鱼采纳,获得10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Energie-Contracting 1500
Représentation chimique de la structure des kérogènes et des asphaltènes en fonction de leur origine et de leur degré d'évolution 1000
Klimaschutzrecht durch den Energiesektor im Mehrebenensystem – Ein Rechtsvergleich 1000
Oncology Clinical Trials: Successful Design, Conduct, and Analysis, Second Edition 800
Ecotourism 400
Genera Orchidacearum Volume 4: Epidendroideae 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8064342
求助须知:如何正确求助?哪些是违规求助? 9487285
关于积分的说明 21341523
捐赠科研通 7632325
什么是DOI,文献DOI怎么找? 3397236
关于科研通互助平台的介绍 2527359
邀请新用户注册赠送积分活动 2435039